HomeStock ScreenerZenlabs EthicaFinancial Statements

Zenlabs Ethica Complete Financial Statements

12 Years of Data
2026 - 2015

In FY2026, Zenlabs Ethica (ZENLABS) reported revenue ₹47 Cr, net profit ₹-2 Cr and EPS ₹-2.97, with a net profit margin of -4.3% and ROE of -22.2%. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Also explore ZENLABS share price data to track price trends across different timeframes.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin -4.26% 2026 data
Operating Margin -1.00% 2026 data
Return on Assets -5.41% 2026 data
Return on Equity -22.22% 2026 data

Balance Sheet Ratios

Current Ratio 17.50 2026 data
Equity Ratio 24.32% 2026 data
Asset Turnover 1.27 2026 data

ZENLABS Revenue, Net Profit & EBITDA — Year-on-Year Growth

ZENLABS YoY (March 2025 vs March 2026) — revenue -9.6%, EBITDA -100.0%, expenses -4.1%. Analyse Zenlabs Ethica shareholding analysis to track promoter, FII and institutional holdings.

Revenue Growth
-9.6%
Year-over-Year
EBITDA Growth
-100.0%
Year-over-Year
Expense Growth
-4.1%
Year-over-Year
Assets Growth
-9.8%
Year-over-Year
Equity Growth
-10.0%
Year-over-Year
Operating Cash Flow Growth
+144.4%
Year-over-Year
Financing Cash Flow Growth
-137.5%
Year-over-Year

ZENLABS Income Statement — Revenue, EBITDA & Net Profit

Zenlabs Ethica revenue ₹47 Cr, EBITDA ₹0 Cr, net profit ₹-2 Cr, EPS ₹-2.97 (2026) — net profit margin -4.3%. For live price, earnings ratios and company overview, see ZENLABS stock price BSE.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Revenue 47 52 59 67 69 57 60 68 72 81 16 0
Expenses 47 49 56 64 67 55 61 65 70 80 16 0
EBITDA 0 3 3 3 3 2 -1 2 2 2 1 0
Operating Profit Margin % -1.00% 5.00% 4.00% 4.00% 3.00% 3.00% -1.00% 3.00% 3.00% 2.00% 1.00% 0.00%
Depreciation 1 1 1 1 1 1 0 0 0 0 0 0
Interest 1 1 1 1 0 0 0 0 0 0 0 0
Profit Before Tax -2 0 1 1 1 1 -1 2 2 1 0 0
Tax 0 0 0 0 0 0 0 1 1 0 0 0
Net Profit -2 0 0 1 1 1 -1 1 1 1 0 0
Earnings Per Share (₹) -2.97 0.41 0.65 0.75 1.20 1.18 -1.13 1.94 1.88 1.53 0.27 -0.18

ZENLABS Balance Sheet — Assets, Liabilities & Shareholders' Equity

ZENLABS total assets ₹37 Cr, total equity ₹9 Cr, total liabilities ₹ Cr (2026) — ROE -22.2%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 37 41 40 44 38 32 34 35 30 33 30 4
Current Assets 35 37 36 38 33 28 32 33 28 31 27 1
Fixed Assets 2 2 4 5 4 4 1 1 1 2 2 0
Capital Work in Progress 0 0 0 0 0 0 0 0 0 0 0 0
Investments 15 1 1 1 1 1 1 1 1 1 0 0
Other Assets 0 38 36 38 34 28 32 33 28 31 29 4
LIABILITIES
Total Liabilities
Current Liabilities 2 2 3 4 3 2 1 1 1 1 1 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 9 10 10 10 9 9 7 8 7 6 5 2
Share Capital 7 7 7 7 7 7 7 7 6 6 6 4
Reserves & Surplus 2 4 4 3 3 2 1 2 1 0 -1 -2

ZENLABS Cash Flow Statement — Operating, Investing & Financing

Zenlabs Ethica operating cash flow ₹4 Cr, investing ₹0 Cr, financing ₹-3 Cr, net cash flow ₹1 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 4 -9 2 0 -8 0 1 0 -1 1 0
Investing Activities 0 0 -2 0 0 0 0 0 0 -2 0
Financing Activities -3 8 0 0 -1 0 0 0 0 3 0
Net Cash Flow 1 -1 0 0 -9 0 0 0 -1 3 0